ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,672,000 | +9.3% | 8,876 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,444,000 | +16193.3% | 8,876 | +17303.9% | 0.00% | – |
| Q4 2020 | $15,000 | -6.2% | 51 | -17.7% | 0.00% | – |
| Q3 2020 | $16,000 | -11.1% | 62 | -24.4% | 0.00% | – |
| Q2 2020 | $18,000 | +63.6% | 82 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -15.4% | 82 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | -99.2% | 82 | -99.4% | 0.00% | -100.0% |
| Q3 2019 | $1,608,000 | -67.3% | 14,111 | -59.4% | 0.00% | -71.4% |
| Q2 2019 | $4,920,000 | +8.7% | 34,750 | -4.1% | 0.01% | 0.0% |
| Q1 2019 | $4,525,000 | -23.6% | 36,250 | -61.4% | 0.01% | -56.2% |
| Q4 2017 | $5,923,000 | +181.4% | 93,812 | 0.0% | 0.02% | +166.7% |
| Q3 2017 | $2,105,000 | -33.8% | 93,812 | -37.5% | 0.01% | -33.3% |
| Q2 2017 | $3,182,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |